Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 12/07/20
End: 10/10/22
Due: 10/10/23
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 10/31/27
Due: 10/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome | NCT04213274 | R-Pharm Overseas, Inc. | user2@example.com | None | 2023-05-31 | 2024-01-31 | 2025-01-31 | - | - | 2025-07-14 |
| Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction | NCT04463251 | R-Pharm Overseas, Inc. | user2@example.com | None | 2020-12-07 | 2022-10-10 | 2023-10-10 | - | - | 2025-07-14 |
| Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis | NCT05107934 | R-Pharm Overseas, Inc. | user2@example.com | None | 2025-12-31 | 2027-10-31 | 2028-10-31 | - | - | 2025-07-14 |